VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AYTU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AYTUAytu BioPharma, Inc.
$2.66$22M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAYTUQuarterly Financials

Aytu BioPharma, Inc. (AYTU) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Aytu BioPharma, Inc. (AYTU) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

AYTU Income Statement

Quarterly statement

AYTU Income Statement

Aytu BioPharma, Inc. (AYTU) annual income statement — 20-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22
Sales/Revenue14.84M16.11M12.41M15.16M13.89M15.13M18.45M16.22M16.57M17.98M14.03M18.75M17.82M30.73M22.73M26.28M27.66M27.45M24.2M23.13M
Revenue Growth %6.87%6.42%-32.74%-6.51%-16.21%-15.8%31.57%-13.48%-6.98%-41.51%-38.31%-28.66%-35.57%11.96%-6.06%13.64%26.3%16.89%79.48%52.67%
Cost of Goods Sold5.41M4.41M5.57M6.07M4.7M4.88M5.65M5.43M4.59M6.07M3.66M4.14M4.78M12.17M9.99M8.99M9.62M14.61M11.51M10.83M
COGS % of Revenue36.42%27.38%44.9%40.01%33.86%32.25%30.6%33.51%27.69%33.77%26.12%22.11%26.82%39.59%43.94%34.19%34.8%53.21%47.58%46.82%
Gross Profit9.44M11.7M6.84M9.1M9.19M10.25M12.81M10.79M11.98M11.91M10.36M14.6M13.04M18.56M12.74M17.29M18.03M12.84M12.69M12.3M
Gross Margin %63.58%72.62%55.1%59.99%66.14%67.75%69.4%66.49%72.31%66.23%73.88%77.89%73.18%60.41%56.06%65.81%65.2%46.79%52.42%53.18%
Gross Profit Growth %2.73%14.06%-46.6%-15.65%-23.35%-13.88%23.6%-26.14%-8.08%-35.87%-18.69%-15.56%-27.7%44.56%0.45%40.6%44.77%13.66%2906.64%38.25%
Operating Expenses12.61M12.47M10.9M11.07M10.69M17.88M10.38M12.48M12.91M15.56M11.96M11.46M13.9M18.39M21.3M24.16M19.84M29.78M66.11M23.59M
OpEx % of Revenue84.93%77.44%87.84%72.98%76.97%118.12%56.28%76.94%77.92%86.54%85.26%61.11%78.04%59.86%93.7%91.94%71.74%108.5%273.18%102.02%
Selling, General & Admin12.61M10.43M10.9M11.07M10.25M8.48M9.3M9.72M10.78M11.09M10.18M10.02M12.39M14.1M19.98M18.58M17.42M17.39M17.36M17.61M
SG&A % of Revenue84.93%64.73%87.84%72.98%73.78%56.01%50.42%59.93%65.07%61.68%72.61%53.44%69.52%45.86%87.89%70.7%63%63.37%71.73%76.16%
Research & Development00000216K162K522K426K1.04M611K521K595K465K856K1.71M1.06M3.25M3.28M4.47M
R&D % of Revenue-----1.43%0.88%3.22%2.57%5.81%4.36%2.78%3.34%1.51%3.77%6.51%3.85%11.85%13.56%19.35%
Other Operating Expenses01000K00444K1000K920K1000K1000K1000K1000K918K924K1000K464K1000K1000K1000K1000K1000K
Operating Income-3.93M-777K-4.06M-1.97M-1.5M-7.62M2.42M-1.7M-930K-3.65M-1.6M3.15M-867K169K-8.56M-6.87M-1.81M-16.94M-53.42M-11.29M
Operating Margin %-26.47%-4.82%-32.75%-12.99%-10.83%-50.37%13.12%-10.45%-5.61%-20.3%-11.39%16.78%-4.87%0.55%-37.65%-26.13%-6.54%-61.72%-220.76%-48.84%
Operating Income Growth %-161.24%89.81%-267.86%-16.22%-61.72%-108.85%251.6%-153.88%-7.27%-2259.76%81.34%145.81%52.05%101%83.98%39.19%93.47%29.63%-108.14%-102.58%
EBITDA-3.93M344K-2.94M-1.08M-701K-6.33M3.71M-522K497K-1.71M-64K4.94M976K2.29M-6.37M-4.66M493K-14.72M-50.85M-8.62M
EBITDA Margin %-26.47%2.14%-23.71%-7.15%-5.05%-41.82%20.1%-3.22%3%-9.49%-0.46%26.33%5.48%7.44%-28%-17.74%1.78%-53.63%-210.12%-37.27%
EBITDA Growth %-460.49%105.44%-179.37%-107.85%-241.05%-270.98%5893.75%-110.57%-49.08%-174.66%98.99%205.9%97.97%115.52%87.48%45.91%101.97%29.06%-114.61%-132.63%
D&A (Non-Cash Add-back)01.12M1.12M885K803K1.29M1.29M1.17M1.43M1.94M1.53M1.79M1.84M2.12M2.19M2.21M2.3M2.22M2.57M2.67M
EBIT0379K-5.17M-10.02M2.48M-18.71M4.72M1.46M2.49M-7.92M-510K2.67M-6.19M2.81M-9.29M-4.19M-1.65M-9.1M-9.46M-11.29M
Net Interest Income0-383K-436K-560K-516K-730K-900K-1.08M-994K-4.79M-1.26M-1.27M-1.28M00-2.5M-1.36M-20.36M-87.18M-534K
Interest Income00000000000000000000
Interest Expense-408K-383K436K560K516K730K900K1.08M994K4.79M1.26M1.27M1.28M002.5M1.36M20.36M87.18M534K
Other Income/Expense48K773K-1.54M-8.61M3.47M-11.82M1.4M2.08M2.43M-272K-170K-1.75M-6.61M-2.63M1.36M175K1.11M851K130K-257K
Pretax Income-3.88M-4K-5.61M-10.58M1.97M-19.44M3.82M382K1.5M-3.92M-1.77M1.4M-7.47M-2.46M-7.2M-6.69M-701K-16.09M-53.29M-11.55M
Pretax Margin %-26.15%-0.02%-45.19%-69.79%14.15%-128.46%20.69%2.35%9.04%-21.82%-12.6%7.46%-41.94%-7.99%-31.67%-25.47%-2.53%-58.62%-220.22%-49.95%
Income Tax0-11K10K00437K-122K-283K405K695K521K780K0000000-3K
Effective Tax Rate %0%275%-0.18%0%0%-2.25%-3.2%-74.08%27.04%-17.72%-29.49%55.75%0%0%0%0%0%0%0%0.03%
Net Income-3.88M-15K-5.62M-10.58M1.97M-19.82M3.99M788K1.47M-4.62M-2.89M-220K-8.12M-2.46M-7.2M-6.69M-701K-16.09M-53.29M-11.55M
Net Margin %-26.15%-0.09%-45.27%-69.79%14.15%-130.94%21.65%4.86%8.89%-25.68%-20.58%-1.17%-45.57%-7.99%-31.67%-25.47%-2.53%-58.62%-220.22%-49.94%
Net Income Growth %-297.51%99.92%-240.66%-1443.15%33.31%-329.24%238.34%458.18%118.15%-87.91%59.9%96.71%-1058.35%84.73%86.49%42.04%97.48%15.31%-109.31%-21.24%
Net Income (Continuing)-3.88M-15K-5.62M-10.58M1.97M-19.88M3.94M665K1.09M-4.62M-2.29M619K-7.47M-2.46M-7.2M-6.69M-701K-16.09M-53.29M-11.55M
Discontinued Operations0000062K54K123K381K0-599K-839K-647K0000000
Minority Interest00000000000000000000
EPS (Diluted)-0.20-0.00-0.53-1.05-0.08-2.920.21-0.260.16-0.83-0.52-0.04-1.48-0.59-1.93-2.15-0.28-8.95-35.90-8.74
EPS Growth %-158.73%99.97%-352.38%-303.85%-148.31%-251.81%140.38%-551.63%110.81%-40.68%73.06%98.14%-428.57%93.41%94.62%75.4%99.94%44.75%-27.3%39.31%
EPS (Basic)-0.20-0.00-0.53-1.050.21-2.920.650.020.20-0.83-0.52-0.04-1.48-0.59-1.93-2.15-0.28-8.95-35.90-8.74
Diluted Shares Outstanding19.33M12.32M10.51M10.04M19.48M6.79M8.2M8.49M9.1M5.54M5.53M5.52M5.48M4.06M3.73M3.11M2.52M1.8M1.48M1.32M
Basic Shares Outstanding19.33M12.32M10.51M10.04M9.44M6.79M6.13M6.13M7.37M5.54M5.53M5.52M5.48M4.06M3.73M3.11M2.52M1.8M1.48M1.32M
Dividend Payout Ratio--------------------